A dual-action implant for bone cancer surgery.
OncoGlass is a gallium-doped bioactive glass designed to be used as a bone filler in the cavity of the resected bone at the time of surgery. Its dual function is to support bone regeneration while exerting selective cytotoxicity against residual tumour cells in and around the surgical site.
Surgical Application
Designed for Bone Void Reconstruction
OncoGlass is intended to be used as a bone void filler at the site of tumour resection. The moldable consistency of the putty allows it to be custom-fit to the surgical defect.
OncoGlass can be manually implanted or delivered with a syringe depending on the geometry and accessibility of the defect.
As the material gradually resorbs, it releases gallium ions locally while supporting bone regeneration at the implant site.
Putty material
Syringe delivery
Bone defect
Application
Filled defect
Our Value
Rethinking bone cancer reconstruction
Dual-action
One implant offering two functions: local control of residual cancer cells and scaffolding for bone regeneration.
Localised treatment
Gallium ions are released directly at the surgical site avoiding systemic toxicity.
Selective cytotoxicity
In vitro evidence shows selective effects against bone cancer cells, and not healthy cells
Mouldable
The putty consistency allows custom fitting to irregular defects.
Resorbable
The material is gradually resorbed as new bone forms.
Local control where radiotherapy is not an option
The location of some tumours makes adjuvant radiotherapy contraindicated.
WHO IT’S FOR
Who OncoGlass is for
OncoGlass is an early-stage technology being developed for clinical translation. We are working closely with surgeons, industry partners, and researchers, and welcome collaborations with anyone whose work intersects with these areas.
Surgery
Orthopaedic oncologists working in the management of bone tumours and post-resection reconstruction.
Industry
Medtech and pharma companies developing bone-void fillers, synthetic grafts, and oncological therapies.
Research
Biomedical engineering, biomaterials, and oncology groups pursuing translational research and collaboration.
Share Your Perspective
We’re engaging with clinicians, researchers, and industry stakeholders to better understand the challenges in bone cancer treatment and reconstruction.